Cargando…

Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors

[Image: see text] Inhibition of soluble epoxide hydrolase (sEH) is indicated as a new therapeutic modality against a variety of inflammatory diseases, including metabolic, renal, and cardiovascular disorders. In our ongoing research on sEH inhibitors, we synthesized novel benzoxazolone-5-urea analog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gur Maz, Tugce, Koc, Beyzanur, Jordan, Paul M., İbiş, Kübra, Çalışkan, Burcu, Werz, Oliver, Banoglu, Erden
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850727/ https://www.ncbi.nlm.nih.gov/pubmed/36687110 http://dx.doi.org/10.1021/acsomega.2c06936

Ejemplares similares

Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation
por: Gazzillo, Erica, et al.
Publicado: (2022)

Quinazoline-4(3H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition
por: Turanlı, Sümeyye, et al.
Publicado: (2022)

Development of an online SPE–LC–MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors
por: Schebb, Nils Helge, et al.
Publicado: (2011)

Misclassification of PfEH1 and PfEH2 as Epoxide Hydrolases
por: Arand, Michael, et al.
Publicado: (2017)

Vascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and ω-Hydroxylases
por: Hanif, Ahmad, et al.
Publicado: (2017)

Reply to “Misclassification of PfEH1 and PfEH2 as Epoxide Hydrolases”
por: Goldberg, Daniel E., et al.
Publicado: (2017)

Optimisation by Design of Experiment of Benzimidazol-2-One Synthesis under Flow Conditions
por: Mostarda, Serena, et al.
Publicado: (2019)

Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201
por: Kretzer, Christian, et al.
Publicado: (2022)

Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents
por: Çalışkan, Burcu, et al.
Publicado: (2018)

Association of the sEH gene promoter polymorphisms and haplotypes with preeclampsia
por: Sarı, İsmail, et al.
Publicado: (2020)

Synthesis, Biological Evaluation and Structure–Activity Relationships of Diflapolin Analogues as Dual sEH/FLAP Inhibitors
por: Vieider, Lisa, et al.
Publicado: (2018)

Activity of sEH and Oxidant Status during Systemic Bovine Coliform Mastitis
por: Mavangira, Vengai, et al.
Publicado: (2021)

Expression, purification, and characterisation of human soluble Epoxide Hydrolase (hsEH) and of its functional C-terminal domain
por: Abis, Giancarlo, et al.
Publicado: (2019)

Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales
por: Kitamura, Seiya, et al.
Publicado: (2017)

Differential Effects of sEH Inhibitors on the Proliferation and Migration of Vascular Smooth Muscle Cells
por: Kim, Hyo Seon, et al.
Publicado: (2017)

Effect Of Dual sEH/COX-2 Inhibition on Allergen-Induced Airway Inflammation
por: Dileepan, Mythili, et al.
Publicado: (2019)

Soluble Epoxide Hydrolase in Atherosclerosis
por: Wang, Yi-Xin Jim, et al.
Publicado: (2010)

Mycobacterial Epoxide Hydrolase EphD Is Inhibited by Urea and Thiourea Derivatives
por: Madacki, Jan, et al.
Publicado: (2021)

Crystal structure and Hirshfeld surface analysis of 1-(2,4-dichlorobenzyl)-5-methyl-N-(thiophene-2-sulfonyl)-1H-pyrazole-3-carboxamide
por: Aydin, Abdullah, et al.
Publicado: (2018)

Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors: In Vitro and In Vivo Anti-Inflammatory Characterization
por: Cerqua, Ida, et al.
Publicado: (2022)

Soluble Epoxide Hydrolase and Diabetes Complications
por: Anita, Natasha Z., et al.
Publicado: (2022)

Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity
por: Turanlı, Sümeyye, et al.
Publicado: (2022)

In Vitro and In Silico Insights into sEH Inhibitors with Amide-Scaffold from the Leaves of Capsicum chinense Jacq.
por: Kim, Jang Hoon, et al.
Publicado: (2018)

sEH Inhibitor Tppu Ameliorates Cecal Ligation and Puncture-Induced Sepsis by Regulating Macrophage Functions
por: Chen, Zhihui, et al.
Publicado: (2020)

Dual sEH/COX-2 Inhibition Using PTUPB—A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity
por: Jankiewicz, Wojciech K., et al.
Publicado: (2021)

Inhibition of Soluble Epoxide Hydrolase for Renal Health
por: Liu, Jun-Yan
Publicado: (2019)

Soluble Epoxide Hydrolase and Brain Cholesterol Metabolism
por: Domingues, Michelle Flores, et al.
Publicado: (2020)

COX-2/sEH Dual Inhibitor PTUPB Alleviates CCl(4)-Induced Liver Fibrosis and Portal Hypertension
por: Zhao, Zhifeng, et al.
Publicado: (2021)

Macrophage Inactivation by Small Molecule Wedelolactone via Targeting sEH for the Treatment of LPS-Induced Acute Lung Injury
por: Zhang, Juan, et al.
Publicado: (2023)

Evaluation of fish models of soluble epoxide hydrolase inhibition.
por: Newman, J W, et al.
Publicado: (2001)

Disrupting Dimerization Translocates Soluble Epoxide Hydrolase to Peroxisomes
por: Nelson, Jonathan W., et al.
Publicado: (2016)

Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
por: Imig, John D., et al.
Publicado: (2020)

The role of soluble epoxide hydrolase and its inhibitors in depression
por: Borsini, Alessandra
Publicado: (2021)

Kampagne „ICH SEH, ICH SEH“ macht auf Diabetes aufmerksam
Publicado: (2020)

Substantially improving the enantioconvergence of PvEH1, a Phaseolus vulgaris epoxide hydrolase, towards m-chlorostyrene oxide by laboratory evolution
por: Zong, Xun-Cheng, et al.
Publicado: (2019)

Encoded Library Synthesis Using Chemical Ligation and the Discovery of sEH Inhibitors from a 334-Million Member Library
por: Litovchick, Alexander, et al.
Publicado: (2015)

Direct targeting of sEH with alisol B alleviated the apoptosis, inflammation, and oxidative stress in cisplatin-induced acute kidney injury
por: Zhang, Juan, et al.
Publicado: (2023)

Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors
por: Kodani, Sean D., et al.
Publicado: (2018)

Epoxide Hydrolases: Multipotential Biocatalysts
por: Bučko, Marek, et al.
Publicado: (2023)

A Soluble Epoxide Hydrolase Inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis
por: Jonnalagadda, Deepa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c9gdo4cchr9affeu673ndcji7k